LX2020 — Regulatory decision
2026
IND-enabling studies and regulatory engagement expected in 2026Source filing
LXEO biotech catalysts & pipeline
LEXEO THERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
LX2020 — Topline data
Q4 2026
12-month data available for all high-dose participants in Q4 2026Source filing
LX2006 — Topline data
H2 2027
Topline data readout expected in second half of 2027Source filing
LX2006 — NDA/BLA submission
H1 2028
Potential BLA submission under accelerated approval pathway in first half of 2028Source filing